为出具本法律意见书，本所律师列席了贵公司本次临时股东大会，并审查了 贵公司提供的以下文件，包括但不限于： 股东大会的通知》； 大会增加临时提案的公告》 本所律师已获得贵公司对其所提供的上述材料的真实性、完整性、准确性的 承诺，本所律师已证实副本材料、复印件与原件一致。 在本法律意见书中，本所律师仅就贵公司本次临时股东大会的召集和召开程 序、出席会议人员的资格、召集人资格、表决程序和表决结果等事项发表法律意 见，不对本次临时股东大会议案的内容以及议案中所涉事实和数据的真实性和准 确性等问题发表意见。 山东众成清泰（潍坊）律师事务所 关 于 潍坊亚星化学股份有限公司 2025 年第三次临时股东大会 的 法律意见书 山东众成清泰（潍坊）律师事务所 中国•潍坊 寒亭区北海路 3777 号总部基地东区 20 号楼 邮政编码：261100 电话：86-532-88959698 传真：86-532-88959698 网址：www.jointide.com 山东众成清泰（潍坊）律师事务所 关于潍坊亚星化学股份有限公司 2025 年第三次临时股东大会的 法律意见书 致：潍坊亚星化学股份有限公司 山东众成清泰（潍坊）律师事务所（ ...

Group 1 - Hubei Changjiang No.1 Health Industry Investment Partnership has been established with a capital contribution of 3.401 billion RMB, primarily funded by Hubei Changjiang Industrial Investment Fund Co., Ltd. and Hubei Changjiang New Kinetic Energy Private Fund Management Co., Ltd. [1] - The fund aims to accelerate the development of the biopharmaceutical and health industry in Hubei, which is a key strategic pillar industry for the province, projected to reach a trillion-level scale [1][3]. - The establishment of the fund is expected to effectively promote the construction of biopharmaceutical industrial parks and project introductions [1]. Group 2 - Guangji Pharmaceutical, as the only provincial-level listed pharmaceutical company in Hubei, is a significant subsidiary of Changjiang Industrial Group, producing various vitamin products and serving as a major supplier of Vitamin B2 globally [2]. - The fund will provide strong capital support for Guangji Pharmaceutical in terms of industrial collaboration, project implementation, mergers, and development [2]. - The fund will also establish an expert committee to provide intellectual support for project advancement, enhancing the scientific and forward-looking aspects of industry development [2]. Group 3 - Changjiang Industrial Group was established in January 2022, with a registered capital of 33.6 billion RMB and total assets of 250.9 billion RMB, managing over 700 billion RMB in funds [3]. - The health industry in Hubei has surpassed 850 billion RMB in scale, accounting for 15% of the province's GDP, with expectations to exceed 950 billion RMB by 2025, reflecting a compound annual growth rate of 12%-15% [3]. - The "14th Five-Year Plan" for the development of the health industry in Hubei includes the establishment of a 10 billion RMB guiding fund to support sectors such as biopharmaceuticals and medical devices [3]. Group 4 - By the end of 2024, the number of high-tech enterprises in Hubei's health sector is expected to exceed 1,500, marking a 65% increase since 2020 [4]. - In the chemical pharmaceutical sector, companies like Renfu Pharmaceutical and Yuanda Pharmaceutical lead in specific markets such as anesthetics and eye drops [4]. - Wuhan Optics Valley Biomedicine City has over 400 biopharmaceutical companies, forming a regional cluster advantage in areas like genetic engineering and vaccine development [4].

Core Viewpoint - Multiple listed companies in the Shanghai and Shenzhen markets have announced significant changes in their financial forecasts and strategic decisions, indicating varied performance across different sectors in the first half of 2025 [1][3]. Company Announcements - Zhonghua Equipment plans to acquire 100% stakes in Yiyang Rubber and Plastic Machinery Group and Beihua Machinery, with stock suspension starting July 15, 2025, for up to 10 trading days [3]. - Jiugui Liquor expects a net profit decline of 90.08% to 93.39% in the first half of 2025, with projected revenue around 560 million yuan, a decrease of approximately 43% year-on-year [5]. - Suli Co. anticipates a net profit increase of 1008.39% to 1223.91%, with expected profits between 72 million and 86 million yuan, driven by improved market conditions [6]. - Te Yi Pharmaceutical forecasts a net profit growth of 1164.22% to 1312.95%, with profits expected between 34 million and 38 million yuan, supported by strong sales of its core product [7]. - Huahong Technology predicts a net profit increase of 3047.48% to 3721.94%, with expected profits between 70 million and 85 million yuan, benefiting from rising rare earth product prices [8]. - Huaxia Airlines expects a net profit increase of 741.26% to 1008.93%, with profits projected between 220 million and 290 million yuan, due to improved demand for air travel [9]. - Xianfeng Holdings anticipates a net profit increase of 524.58% to 671.53%, with expected profits between 34 million and 42 million yuan, largely due to non-recurring gains [10]. - Xinyisheng expects a net profit increase of 327.68% to 385.47%, with profits projected between 370 million and 420 million yuan, driven by growth in AI-related investments [12]. - Hengsheng Electronics forecasts a net profit increase of approximately 740.95%, with expected profits around 251 million yuan, aided by significant non-recurring gains [13]. - CICC anticipates a net profit increase of 55% to 78%, with expected profits between 3.453 billion and 3.966 billion yuan, driven by growth in investment banking and wealth management [14]. - Xinda Securities expects a net profit increase of 50% to 70%, with profits projected between 921 million and 1.044 billion yuan, supported by improved asset management [15]. - Shanxi Securities forecasts a net profit increase of 58.17% to 70.72%, with expected profits between 504 million and 544 million yuan, driven by growth in wealth management and international business [16]. - Guocheng Mining anticipates a net profit increase of 1046.75% to 1174.69%, with expected profits between 493 million and 548 million yuan, primarily due to non-recurring gains from asset sales [17]. - China Rare Earth expects a net profit of 136 million to 176 million yuan, recovering from a loss of 244 million yuan in the previous year, aided by improved market conditions [18]. - Perfect World anticipates a net profit of 480 million to 520 million yuan, recovering from a loss of 177 million yuan, driven by successful game launches and esports growth [19]. - Huanghe Xuanfeng expects a net loss of 285 million yuan, impacted by intense competition and weak demand in the superhard materials sector [20][21]. - JA Solar forecasts a net loss of 2.5 billion to 3 billion yuan, worsening from a loss of 874 million yuan, due to industry-wide supply-demand imbalances [22]. - Shanxi Black Cat anticipates a net loss of 490 million to 540 million yuan, driven by declining sales and prices of its main products [23]. - Xinda Real Estate expects a net loss of 3.5 billion to 3.9 billion yuan, transitioning from profit to loss due to reduced project deliveries and impairment provisions [24]. Major Contracts - Zhongchen Co. won a project from Southern Power Grid worth 379 million yuan, representing 12.26% of its audited revenue for 2024 [26]. - Gaode Infrared signed a procurement agreement for a complete equipment system worth 879 million yuan, accounting for 32.84% of its 2024 audited revenue, expected to positively impact this year's performance [27].

Group 1 - Aerospace Science and Technology expects a net profit of 68 million to 95 million yuan for the first half of 2025, representing a growth of 1628.83% to 2315.27% compared to the same period last year [1] - Huaxia Airlines anticipates a net profit of 220 million to 290 million yuan for the first half of 2025, an increase of 741.26% to 1008.93% year-on-year [1] - Shida Group forecasts a net loss of 44 million to 65 million yuan for the first half of 2025, marking a shift from profit to loss [1] Group 2 - Jiaao Environmental Protection expects a net loss of 70 million to 90 million yuan for the first half of 2025 [3] - Haima Automobile predicts a net loss of 60 million to 90 million yuan for the first half of 2025, compared to a loss of 152 million yuan in the same period last year [3] - Huaibei Mining anticipates a net profit of approximately 1.027 billion yuan for the first half of 2025, a decrease of about 65% year-on-year [3] Group 3 - Quanfu Automobile expects a net loss of 155 million to 185 million yuan for the first half of 2025 [5] - Gaode Infrared signed a procurement agreement worth 879 million yuan, which is expected to positively impact its operating performance for the year [5] - Zhongchen Co. won a project from Southern Power Grid worth 379 million yuan, representing 12.26% of its audited revenue for 2024 [5] Group 4 - Daheng Technology anticipates a net loss of 406,000 yuan for the first half of 2025, compared to a loss of 988,250 yuan in the same period last year [6] - Dazhongnan expects a net profit of 6.5 million to 8 million yuan for the first half of 2025, a recovery from a loss of 15.325 million yuan last year [6] - Xianfeng Holdings projects a net profit of 34 million to 42 million yuan for the first half of 2025, a year-on-year increase of 524.58% to 671.53% [7] Group 5 - Shuangxiang Co. expects a net profit of 115 million to 150 million yuan for the first half of 2025, a growth of 128.1% to 197.53% year-on-year [8] - ST Xintong anticipates a net loss of 67 million to 97 million yuan for the first half of 2025 [9] - Jishi Media forecasts a net loss of 187 million to 233 million yuan for the first half of 2025 [10] Group 6 - Suli Co. expects a net profit of 72 million to 86 million yuan for the first half of 2025, a year-on-year increase of 1008.39% to 1223.91% [11] - Wanli Co. anticipates a net loss of 19 million yuan for the first half of 2025, compared to a loss of 12.9238 million yuan last year [12] - Langzi Co. projects a net profit of 22 million to 26 million yuan for the first half of 2025, an increase of 31.74% to 55.69% year-on-year [14] Group 7 - Changjiang Securities expects a net profit of 1.652 billion to 1.81 billion yuan for the first half of 2025, a growth of 110% to 130% [15] - Huahong Technology anticipates a net profit of 70 million to 85 million yuan for the first half of 2025, a year-on-year increase of 3047.48% to 3721.94% [16] - Chenhua Co. plans to invest 30 million yuan in financial products with an expected annual yield of 3.20% [16] Group 8 - Zijing Mining expects a net profit of approximately 23.2 billion yuan for the first half of 2025, a growth of about 54% year-on-year [28] - Limin Co. anticipates a net profit of 26 million to 28 million yuan for the first half of 2025, a year-on-year increase of 719.25% to 782.27% [29] - Huazhong Securities expects a net profit of 1.035 billion yuan for the first half of 2025, a growth of 44.94% year-on-year [30]

交易咨询业务资格：证监许可【2012】1091号 甲醇周报 （7.7 大越期货投资咨询部 -7.11 金泽彬 ） 从业资格证号：F3048432 投资咨询证号：Z0015557 联系方式：0575-85226759 重要提示：本报告非期货交易咨询业务项下服务，其中的观点和信息仅作参考之用，不构成对任何人的投 资建议。 我司不会因为关注、收到或阅读本报告内容而视相关人员为客户；市场有风险，投资需谨慎。 CONTENTS 目 录 1 每周评论 2 基本面数据 3 检修状况 4 观点与策略 国内甲醇现货价格 | | | | 国内甲醇价格 | | （元/吨） | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 7月4日 | 7月8日 | 7月9日 | | 7月10日 | 7月11日 | | 周涨跌 | | | 江苏 2445 | 2402 | 2385 | | 2390 | 2368 | - 3 . | 15% | | | 鲁南 2230 | 2230 | 2230 | | 2230 | 2230 | 0 . | 00% | | | ...

Investment Rating - The report does not explicitly state the investment rating for North Chemical Industries Core Insights - North Chemical Industries is a global leader in nitrocellulose production, established in 2002 and listed on the Shenzhen Stock Exchange in 2008. The company has three main business areas: nitrocellulose, special industrial pumps, and activated carbon and protective equipment. It has maintained a leading position in global production and sales of nitrocellulose since 2004, with products sold to over 50 countries and regions [2][4][5] Financial Performance - For the first half of 2025, the net profit attributable to the parent company is expected to be between RMB 98 million and RMB 111 million, representing a year-on-year increase of 182.72% to 220.23%. The non-recurring net profit is expected to be between RMB 71 million and RMB 84 million, indicating a year-on-year increase of 1,387.97% to 1,660.42%. The growth is attributed to increased revenue and improved product gross profit margins [3][5] Business Segments - The company is recognized as the most comprehensive nitrocellulose manufacturer in the industry, producing three main product lines and over 80 grades of nitrocellulose, with applications in various fields including coatings and biomedical membranes [3][5] - The chemical defense and environmental protection business targets the mid-to-high-end market, focusing on developing environmental protection equipment centered on activated carbon deep adsorption purification devices [3][5] - The special industrial pump segment has a high market share, with a 70% market share in the phosphorous chemical industry and a 40% market share in flue gas desulfurization pumps in China [3][5]

Group 1: Company Overview and Product Information - The company has four production bases, with key products including Vitamin K3, chromium tanning agents, and various pharmaceutical raw materials [1] - The main applications of para-hydroxyphenol span multiple industries, including food, daily chemicals, pesticides, pharmaceuticals, dyes, and polymer materials [1] - The company has officially started selling para-hydroxyphenol in the PEEK field and is currently in the verification stage with major domestic PEEK manufacturers [2] Group 2: Regulatory Approvals and Product Registration - The company has obtained various regulatory approvals for iodine contrast agents, including registrations in China, India, Japan, and CEP certification [2] - Currently, the company holds registration certificates for two formulation products, with one product, Bisoprolol fumarate tablets, having commenced market promotion in 2024 [2] Group 3: Financial Performance and Inventory Management - The growth in performance for the first half of 2025 is attributed to the year-on-year price increase of certain vitamin products and a decrease in production costs [2] - The company maintains a large ending inventory balance due to its diverse product lines, which include vitamins, flavors, raw materials, and chromium salts, and is focused on improving asset turnover efficiency [2] Group 4: Supply Chain and Procurement - The company sources chromium ore locally in South Africa as needed and currently has no plans to acquire chromium mines [2] Group 5: Disclosure and Compliance - The investor relations activity did not involve any undisclosed significant information [2]

Core Viewpoint - The company expects a significant decrease in net profit for the first half of 2025, with projections indicating a decline of 56.15% to 70.77% year-on-year [1] Financial Performance - The estimated net profit attributable to shareholders for the first half of 2025 is projected to be between 22 million to 33 million yuan [1] - After excluding non-recurring gains and losses, the expected net profit is forecasted to be between 19 million to 28 million yuan, reflecting a year-on-year decrease of 69.33% to 79.19% [1] Operational Challenges - The decline in net profit is primarily attributed to the company's wholly-owned subsidiary, Shandong Wansheng New Materials Co., Ltd., which is in the process of establishing a new production base [1] - The production capacity is still ramping up and has not yet fully realized economies of scale, leading to increased costs such as fixed asset depreciation and management expenses [1]

Market Performance - The FTSE China A50 Index components showed strong performance in the power, coal, and oil sectors, while the banking and liquor sectors experienced mixed results [1] - Notable market capitalization figures include China Petroleum at 16,252.26 billion, China Shenhua at 7,434.80 billion, and Kweichow Moutai at 1,788.32 billion [3][4] Sector Highlights - **Power Sector**: Strong performance noted, with significant trading volumes [1] - **Coal Sector**: China Shenhua's stock increased by 0.62 (+1.68%) with a market cap of 7,434.80 billion [3] - **Oil Sector**: China Petroleum's stock rose by 0.06 (+1.05%) with a market cap of 16,252.26 billion [3] - **Banking Sector**: Mixed results with China Everbright Bank showing a slight increase of 0.05 (+1.15%) [3] - **Liquor Sector**: Kweichow Moutai decreased by 3.40 (-0.24%) while other brands showed slight increases [3] Trading Volumes - Significant trading volumes were observed in various sectors, with the power sector leading [1] - China Petroleum had a trading volume of 7.29 billion, while China Shenhua had 55.02 billion [3] Company Specifics - **China Ping An**: Market cap of 3,781.15 billion with a trading volume of 9.71 billion, showing a slight decrease of 0.16 (-0.42%) [3] - **Ningde Times**: Market cap of 3,453.66 billion with a trading volume of 21.43 billion, decreased by 0.25 (-0.87%) [4] - **Kweichow Moutai**: Market cap of 1,788.32 billion with a trading volume of 39.62 billion, decreased by 3.40 (-0.24%) [3]

Group 1 - The 12th World Congress of Chemical Engineering and the 21st Asia-Pacific Chemical Alliance Conference (WCCE12 & APCChE2025) is being held in Beijing, marking the first time these two major events are combined in China, aiming to foster global collaboration in the chemical engineering sector [2][3] - The conference theme is "Chemical Engineering Paradigm Shift to Meet Global Challenges," focusing on international academic exchange and the integration of industry, academia, and research [3][4] - The event has attracted nearly 5,000 top scientists, industry leaders, and corporate elites from 66 countries across six continents, emphasizing the importance of knowledge sharing and collaborative innovation in the chemical industry [2][3][6] Group 2 - The conference addresses global challenges such as climate change, energy transition, and industrial chain restructuring, with discussions on how traditional chemical industries can adapt and innovate [6][10] - A total of 50 activities will be held over five days, including keynote speeches, thematic sessions, and an international innovation exhibition, aimed at promoting technological advancements and sustainable development in the chemical sector [10] - The accompanying 2025 International Chemical Innovation Exhibition features over 130 global companies and institutions, showcasing innovative products and technologies, and aims to bridge the gap between the public and chemical technology [7][9]